<DOC>
	<DOC>NCT00832169</DOC>
	<brief_summary>The aim of this study is to get information about absorption, distribution, metabolism and excretion as well as the tolerability and safety of AZD1386 in healthy male volunteers.</brief_summary>
	<brief_title>Investigation of Rate+Extent of Excretion of Radioactivity in Urine+Faeces After Oral Administration of [14C]AZD1386</brief_title>
	<detailed_description />
	<criteria>Body Mass Index of 18 30 and weight of 50 to 100 kilos. Healthy volunteer must have regular bowel movements (at least once daily) History of psychiatric or somatic disease/condition, which may interfere with the objectives of the study as judged by the investigator. A family history of short QT syndrome or sudden cardiac death amongst first degree relatives. Any clinically important abnormalities in heart rhythm, conduction or morphology of resting ECG that may interfere with the interpretation of QTc interval changes.</criteria>
	<gender>Male</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Pain</keyword>
</DOC>